Ketorolac Tromethamine Injection, USP

Hazard statements (CLP)

H225, H315, H319

Code

Statements

H225

Highly Flammable liquid and vapour

SECTION 2: Hazards identification

1999/45/EC EMERGENCY OVERVIEW

Product definition

This product is a clear, colorless to slightly yellow liquid with no odor

Health hazards

Common adverse effects to excessive exposure include nausea, vomiting, gastrointestinal irritation, diarrhea, fatigue, insomnia, headache and dizziness. Flammability Hazards: This product is combustible with a flash point of 106⁰F. Reactivity Hazards: None known

Environmental hazards

The Environmental effects of this product have not been investigated. Release of this product is not expected to have significant adverse effects in the aquatic environment. US DOT SYMBOLS

Signal word

Danger!

Classification according to GHS

Flammable Liquid Category 2 Skin Irritant Category 2 Eye Irritant Category 2

Hazard statements

H225 Flammable liquid and vapor H315: Causes skin irritation H319: Causes Eye irritation

Precautionary statements

P210: Keep away from flames and hot surfaces. No Smoking P264: Wash skin after handling.

Response

P305+P351+P338 IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing

Storage

P403+P235: Store in a well ventilated place. Keep cool

Disposal

P501: Dispose of contents/container in accordance with local/regional/national/international regulations Other Known Hazard(s): This mixture has not been tested to the criteria for PBT or vPvB in accordance with Annex VII. No other hazards known 2.3 HEALTH HAZARDS OR RISKS FROM EXPOSURE: SYMPTOMS OF OVEREXPOSURE BY ROUTE OF EXPOSURE: The most significant routes of exposure for this product are by injection, ingestion, inhalation and skin or eye contact. ACUTE: Common adverse effects to excessive exposure include nausea, vomiting, gastrointestinal irritation, diarrhea, fatigue, insomnia, headache and dizziness. CHRONIC: Chronic toxicity will result only on excessive repetitive exposure. Chronic Toxicity effects may be seen at the digestive system. TARGET ORGANS Acute Skin, Eyes, Digestive System Chronic: Digestive System

2.1 Classification of the substance or mixture

EUROPEAN UNION DIRECTIVES: This product does meet the definition of a hazardous substance or preparation as defined by 29 CFR 1910. 1200 AND the European Union Council Directives 67/548/EEC, 1999/45/EC, 1272/2008/EC and subsequent Directives. EU HAZARD CLASSIFICATION OF INGREDIENTS PER DIRECTIVE 1272/2008/EC: EC# 231-791-2 This substance is not classified in the Annex VI EC# 200-578-6 This substance is classified in the Annex VI, Index# 603-002-00-5 EC# 620-545-3 This substance is not classified in the Annex VI EC# 231-132-9 This substance is not classified in the Annex VI Substances not listed either individually or in group entries must be self classified. Component(s) Contributing to Classification(s) All Ingredients